Vgenomics, Meril Genomics partner to improve access to genomic diagnostics in India
Vgenomics
announced their partnership with diagnostics and molecular biology provider
Meril Genomics
to provide complementary advanced
genomic diagnostics
to hospitals and research centers throughout India.
The partnership aims to enhance
precision medicine
accessibility. Initiatives under this partnership include
Non-Invasive Prenatal Testing
(NIPT), which addresses the growing risk of
chromosomal abnormalities
such as Down syndrome, especially among expectant mothers with advanced maternal age. NIPT will facilitate early detection, contributing to safer pregnancies and healthier newborn outcomes across India.
In addition, the collaboration introduces targeted Next-Generation Sequencing (tNGS) for Tuberculosis (TB), significantly impacting India's healthcare landscape, where roughly 26% of Global TB cases occur annually.
The initiative also includes Whole Exome Sequencing (WES) for diagnosing rare diseases, addressing the needs of approximately 70 million affected individuals in India.
Dr. Rahila Sardar, CEO of Vgenomics, said the collaboration reflects a shared commitment to making precision medicine available to more patients, more efficiently.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
13 hours ago
- Business Standard
Fatty liver to liver cancer: Risks, habits, and how to protect yourself
You may not feel it, but your liver could be quietly under stress. Fatty liver disease, called metabolic dysfunction-associated steatotic liver disease (MASLD), now affects one in three Indian adults. While it often starts silently, it can slowly progress to more serious stages such as metabolic-associated steatohepatitis (MASH), cirrhosis, and even liver cancer. Doctors warn that everyday habits—what you eat, how much you move, or whether you drink—can make the difference between a healthy liver and a dangerous diagnosis. How fatty liver progresses to liver cancer Fatty liver involves the accumulation of fat in the liver, typically due to metabolic factors. When this progresses to MASH, marked by inflammation and liver cell damage, it significantly raises the risk of fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) - the most common type of liver cancer. "Fatty liver disease refers to the excessive accumulation of fat in liver cells; it has two main types - Non-Alcoholic Fatty Liver Disease (NAFLD), typically associated with obesity and metabolic syndrome, and Alcohol-Associated Fatty Liver Disease, which results from excessive alcohol use. In the early stages, fatty liver disease is not usually serious, but over time, too much fat can cause inflammation, as well as scarring (fibrosis), which can lead to cirrhosis. The longer a person is in a damaged, unhealthy state increases their chances of liver cancer," explained Dr SK Bala, onco-surgeon at The Calcutta Medical Research Institute (CMRI). "Liver cancer incidence is increased in patients with MASLD and it can occur even before cirrhosis sets in. This is because inflammation in liver cells associated with any of the other risk factors like obesity, alcohol consumption, or superadded viral hepatitis can expedite the evolution of cancer," said Dr Vibha Varma, lead liver transplant and hepato-pancreatic-biliary surgeon, Lilavati Hospital, Mumbai. Everyday habits that add to the risk It's not just rare medical conditions that put your liver at risk—daily lifestyle choices play a huge role. Doctors point to common habits that worsen fatty liver and set the stage for cancer: Eating too much sugar, refined carbs, and processed foods Long hours of sitting and lack of physical activity Relying on fried, junk, or fast food high in salt, oil, and preservatives Gaining belly fat, which raises inflammation and cancer risk Drinking alcohol and smoking, which accelerate liver damage Ignoring fatigue, abdominal discomfort, or abnormal test results "Central obesity causes insulin resistance, which is the hallmark of MASLD. Acceleration is brought about by type 2 diabetes due to oxidative stress and increased fat accumulation within hepatocytes," said Dr Varma. Warning signs to watch for Because fatty liver is often silent, it's easy to miss the early warnings. Still, doctors say there are some signals worth paying attention to: Persistent fatigue Upper-right abdominal discomfort Raised liver enzymes on routine blood tests Enlarged liver detected in scans "Initially, fatty liver does not show any symptoms. But as the condition worsens—mostly fatigue, unexplained weight loss, pain or heaviness in the right side of the abdomen, yellowing of the eyes or skin (jaundice), and swelling of the legs or abdomen may appear. People at risk should get liver tests done regularly," said Dr G Swathi, consultant gastroenterology and haematology, CARE Hospitals, Hyderabad. Why regular testing matters Since fatty liver often shows no symptoms in its early stages, regular testing is crucial. Experts suggest simple blood tests, such as liver function tests, can help reveal raised enzyme levels that may indicate trouble. Ultrasound scans can help detect fat build-up and assess liver stiffness. For people with risk factors such as obesity, diabetes, or heavy alcohol use, early testing helps catch the disease before it progresses. "Today, we can detect fatty liver infiltration years before conventional tests flag anything. AI-powered detection of advanced biomarkers reveals the molecular signature of early disease, even when your labs read normal," added Sid Das, founder of (AI-powered platform to analyse genomic data and develop personalized health interventions.) Can fatty liver be reversed? Fatty liver can often be reversed, especially in the early stages, with lifestyle modifications. Before fibrosis sets in, healthy changes can help restore liver function. Dr Varma shared some tips: Lose 5–10 per cent of your body weight to cut down liver fat Follow a Mediterranean-style diet with vegetables, whole grains, fish, nuts, and olive oil Reduce added sugars and sugary drinks Eat more fibre, omega-3s, and antioxidant-rich foods like flaxseeds, berries, turmeric, and olive oil Sleep well and avoid late-night meals Quit alcohol and smoking Keep diabetes, blood pressure, and cholesterol under control with proper treatment "Studies suggest that up to 70–80 per cent of liver cancer cases related to fatty liver disease are preventable through lifestyle changes. By maintaining a healthy weight, eating a balanced diet, exercising regularly, and controlling diabetes, individuals can significantly reduce their risk of fatty liver progressing to cirrhosis and cancer," said Dr Bala.
The Hindu
a day ago
- The Hindu
NGO urges State to issue special health card for children with long-term illness
Thrissur-based NGO Solace, working with children suffering from life-threatening illnesses for the past 18 years, has urged the State government to introduce a special health card for 'Children with Long-Term Illness' (CLI) to ensure uninterrupted access to essential medicines and healthcare. The appeal has been made by Sheeba Ameer, founder of Solace, in a recent memorandum to Chief Minister Pinarayi Vijayan, stressing that these children and their families face severe medical, social and financial challenges every day. 'These children need not just palliative care, but sustained medical support to stay alive. Government schemes must focus on treatment and daily medicines, not just symptom relief,' the memorandum states. Costly medicines Children with conditions such as cancer, muscular dystrophy, nephrotic syndrome, haemophilia, thalassemia, cardiovascular diseases, epilepsy, Crohn's disease, Down syndrome, autism, renal failure and juvenile diabetes depend on costly medicines, often consumed daily for survival. The NGO currently spends ₹35 lakh a month on medicines, which covers barely half of the children's needs. 'If we had to meet the entire cost, it would be more than double,' Ms. Ameer pointed out, urging the government to take over this critical support. The proposed CLI health card would allow families to obtain free or subsidised medicines from all government medical colleges, district hospitals and health centres. While several Central and State schemes exist, 'funds are rarely allocated effectively, and medicines often remain unavailable,' she noted. The NGO also flagged the acute social and psychological struggles of parents. Many are unable to work due to constant caregiving, leaving families unable to afford rent, food, or even funeral costs if a child dies. 'Some families are pushed to the brink of suicide because of debt and despair,' the note warned. Special protocols Adding urgency, the NGO highlighted that during floods and natural disasters, children on immunosuppressive drugs cannot be shifted to regular relief camps, demanding special rehabilitation protocols. 'The government must recognise children with long-term illness as a distinct category and act with urgency,' Ms. Ameer said. 'It is not just about treatment—it is about dignity and survival.'
Time of India
3 days ago
- Time of India
Medistep Healthcare shares to list today. Here's what GMP suggests
Shares of Medistep Healthcare will debut on the NSE SME platform on Monday. The stock is commanding a strong grey market premium (GMP) of around 19%, suggesting healthy listing gains for investors. The Rs 16.10 crore IPO, which was open for subscription from August 8 to August 12, saw an overwhelming response, with an overall subscription of 382.14 times. The retail portion was subscribed to an exceptional 461.11 times, while Non-Institutional Investors (NII) subscribed 289.15 times. Priced at Rs 43 per share, the issue was entirely a fresh issue of 37.44 lakh shares. The company plans to utilise the proceeds for working capital, purchase of plant and machinery for expansion, and general corporate purposes. Incorporated in June 2023, Medistep Healthcare manufactures and trades a diverse range of products, including sanitary pads, nutraceuticals, pharmaceutical items, surgical supplies, and intimate care products. For FY25, the company reported revenue of Rs 49.66 crore and profit after tax of Rs 4.14 crore, reflecting growth of 27% and 25% respectively over FY24. Live Events While analysts note the company operates in a highly competitive and fragmented segment, the robust subscription figures and positive GMP signal strong investor appetite. All eyes will now be on the listing, where the stock is expected to debut at a healthy premium over the issue price. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
